MGRM | Monogram Orthopaedics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.4100 - 2.6200
52 Week Range	1.5300 - 4.90
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	116,478
Average Volume	104,971
Shares Outstanding	34,312,260
Market Cap	88,525,631
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2023-05-18

Valuation
Profitability
Growth
Health
P/E Ratio	-5.49
Forward P/E Ratio	N/A
EPS	-0.47
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	28
Country	USA
Website	MGRM

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

MGRM's peers: BFLY, MASS, NNOX, SENS

*Chart delayed

Analyzing fundamentals for MGRM we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong. For more detailed analysis please see MGRM Fundamentals page.

Watching at MGRM technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on MGRM Technicals page.